chr2-168871505-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020675.4(SPC25):c.601G>A(p.Val201Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,609,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020675.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SPC25 | NM_020675.4 | c.601G>A | p.Val201Ile | missense_variant | 7/7 | ENST00000282074.7 | |
SPC25 | XM_011511516.3 | c.550+2080G>A | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SPC25 | ENST00000282074.7 | c.601G>A | p.Val201Ile | missense_variant | 7/7 | 1 | NM_020675.4 | P1 | |
SPC25 | ENST00000479309.6 | n.419+2080G>A | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000594 AC: 9AN: 151576Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000525 AC: 13AN: 247766Hom.: 0 AF XY: 0.0000598 AC XY: 8AN XY: 133818
GnomAD4 exome AF: 0.0000652 AC: 95AN: 1457490Hom.: 0 Cov.: 31 AF XY: 0.0000635 AC XY: 46AN XY: 724724
GnomAD4 genome AF: 0.0000594 AC: 9AN: 151576Hom.: 0 Cov.: 31 AF XY: 0.0000946 AC XY: 7AN XY: 73998
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 31, 2023 | The c.601G>A (p.V201I) alteration is located in exon 7 (coding exon 6) of the SPC25 gene. This alteration results from a G to A substitution at nucleotide position 601, causing the valine (V) at amino acid position 201 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at